OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Prognostic MicroRNA Panel for HCV-Associated HCC: Integrating Computational Biology and Clinical Validation
Areeg M. Dabbish, Hana Abdelzaher, Moustafa Abohawya, et al.
Cancers (2022) Vol. 14, Iss. 13, pp. 3036-3036
Open Access | Times Cited: 9
Areeg M. Dabbish, Hana Abdelzaher, Moustafa Abohawya, et al.
Cancers (2022) Vol. 14, Iss. 13, pp. 3036-3036
Open Access | Times Cited: 9
Showing 9 citing articles:
A Comprehensive Insight and In Silico Analysis of CircRNAs in Hepatocellular Carcinoma: A Step toward ncRNA-Based Precision Medicine
R.A. Youness, Hossam A. Hassan, Tasneem Abaza, et al.
Cells (2024) Vol. 13, Iss. 15, pp. 1245-1245
Open Access | Times Cited: 9
R.A. Youness, Hossam A. Hassan, Tasneem Abaza, et al.
Cells (2024) Vol. 13, Iss. 15, pp. 1245-1245
Open Access | Times Cited: 9
Biomarker discovery and application—An opportunity to resolve the challenge of liver cancer diagnosis and treatment
Jingtao Chen, Chao Niu, Ning Yang, et al.
Pharmacological Research (2023) Vol. 189, pp. 106674-106674
Open Access | Times Cited: 18
Jingtao Chen, Chao Niu, Ning Yang, et al.
Pharmacological Research (2023) Vol. 189, pp. 106674-106674
Open Access | Times Cited: 18
An Insight into the Arising Role of MicroRNAs in Hepatocellular Carcinoma: Future Diagnostic and Therapeutic Approaches
Evangelos Koustas, Eleni-Myrto Trifylli, Panagiotis Sarantis, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7168-7168
Open Access | Times Cited: 11
Evangelos Koustas, Eleni-Myrto Trifylli, Panagiotis Sarantis, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7168-7168
Open Access | Times Cited: 11
MicroRNAs as Plasma Biomarkers of Hepatocellular Carcinoma in Patients with Liver Cirrhosis—A Cross-Sectional Study
Robin Zenlander, Hugh Salter, Stefan Gilg, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2414-2414
Open Access | Times Cited: 4
Robin Zenlander, Hugh Salter, Stefan Gilg, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2414-2414
Open Access | Times Cited: 4
Predicting hepatocellular carcinoma outcomes and immune therapy response with ATP-dependent chromatin remodeling-related genes, highlighting MORF4L1 as a promising target
Chao Xu, Litao Liang, Guoqing Liu, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Chao Xu, Litao Liang, Guoqing Liu, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Potential role of microRNAs in personalized medicine against hepatitis: a futuristic approach
Sonam Gupta, Shama Parveen
Archives of Virology (2024) Vol. 169, Iss. 2
Closed Access | Times Cited: 3
Sonam Gupta, Shama Parveen
Archives of Virology (2024) Vol. 169, Iss. 2
Closed Access | Times Cited: 3
Clinical Application of Different Liquid Biopsy Components in Hepatocellular Carcinoma
Jing Xu, Yuanyuan Zhao, Zhishui Chen, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 4, pp. 420-420
Open Access | Times Cited: 2
Jing Xu, Yuanyuan Zhao, Zhishui Chen, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 4, pp. 420-420
Open Access | Times Cited: 2
MicroRNA let-7c-5p Alleviates in Hepatocellular Carcinoma by Targeting Enhancer of Zeste Homolog 2: A Study Intersecting Bioinformatic Analysis and Validated Experiments
Tianyu Lin, Xinli Guo, Qian Du, et al.
Critical Reviews in Immunology (2024) Vol. 44, Iss. 4, pp. 23-39
Closed Access
Tianyu Lin, Xinli Guo, Qian Du, et al.
Critical Reviews in Immunology (2024) Vol. 44, Iss. 4, pp. 23-39
Closed Access
Meeting the challenges of HCC post SVR in the Post-DAA Era: A Path Forward
Seren M. Gedallovich, Paul Y. Kwo
Clinical and Molecular Hepatology (2024)
Open Access
Seren M. Gedallovich, Paul Y. Kwo
Clinical and Molecular Hepatology (2024)
Open Access
